ALEXIS SHAFII to Humans
This is a "connection" page, showing publications ALEXIS SHAFII has written about Humans.
Connection Strength
0.322
-
Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall. J Thorac Cardiovasc Surg. 2022 06; 163(6):2129-2130.
Score: 0.020
-
Simple Felt-Plug Closure Technique for Minimally Invasive Removal of a Centrifugal-Flow Left Ventricular Assist Device. Tex Heart Inst J. 2020 08 01; 47(4):322-324.
Score: 0.018
-
Does Overtreatment of Heart Transplantation Candidates Exist? J Am Coll Cardiol. 2018 08 07; 72(6):702-703.
Score: 0.016
-
Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case Report. Transplant Proc. 2017 Sep; 49(7):1682-1684.
Score: 0.015
-
Too high for transplantation? Single-center analysis of the lung allocation score. Ann Thorac Surg. 2014 Nov; 98(5):1730-6.
Score: 0.012
-
Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation. ASAIO J. 2012 Sep-Oct; 58(5):526-9.
Score: 0.010
-
Subclavian insertion of the bicaval dual lumen cannula for venovenous extracorporeal membrane oxygenation. Ann Thorac Surg. 2012 Aug; 94(2):663-5.
Score: 0.010
-
High incidence of upper-extremity deep vein thrombosis with dual-lumen venovenous extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):988-9.
Score: 0.010
-
Changes in left ventricular morphology and function after mitral valve surgery. Am J Cardiol. 2012 Aug 01; 110(3):403-408.e3.
Score: 0.010
-
Fate of retained right ventricular assist device outflow grafts after right ventricular recovery. J Heart Lung Transplant. 2012 Jun; 31(6):672-3.
Score: 0.010
-
Total arch replacement after a failed repair for Takayasu's ascending aortitis. Ann Thorac Surg. 2012 Jan; 93(1):300-2.
Score: 0.010
-
Coincidental alignment of extracorporeal oxygenator cannula and central venous catheter. Ann Thorac Surg. 2011 Oct; 92(4):1529.
Score: 0.010
-
Omental flap transposition with intra-abdominal relocation for LVAD pump-pocket infection. J Heart Lung Transplant. 2011 Dec; 30(12):1421-2.
Score: 0.010
-
The effect of recipient hepatitis C virus infection on outcomes following heart transplantation. Transplant Proc. 2010 Jun; 42(5):1784-7.
Score: 0.009
-
Predicting Sepsis in Heart Failure Patients Supported by Left Ventricular Assist Devices: The Role of VE-Cadherin and ADAM10. Int J Mol Sci. 2026 Jan 06; 27(2).
Score: 0.007
-
Preoperative brain volume loss is associated with postoperative delirium in advanced heart failure patients supported by left ventricular assist device. Sci Rep. 2025 Mar 14; 15(1):8884.
Score: 0.006
-
Endostatin and Cystatin C as Predictors of 1 Month Renal Function Change in Patients With Left Ventricular Assist Device Support. ASAIO J. 2025 Oct 01; 71(10):785-794.
Score: 0.006
-
Machine Learning Assisted Stroke Prediction in Mechanical Circulatory Support: Predictive Role of Systemic Mitochondrial Dysfunction. ASAIO J. 2025 05 01; 71(5):387-394.
Score: 0.006
-
Effect of Preoperative Mitral Regurgitation on LVAD Outcomes in Patients with Elevated Pulmonary Vascular Resistance. Cardiovasc Drugs Ther. 2025 Oct; 39(5):1085-1095.
Score: 0.006
-
Minimally Invasive Mitral Valve Surgery Using a Cold Fibrillatory Cardiac Arrest Technique in Patients With Prior Cardiac Surgery. Tex Heart Inst J. 2024 07 19; 51(2).
Score: 0.006
-
Risk Factors, Incidence, and Outcomes Associated With Clinically Significant Airway Ischemia. Transpl Int. 2024; 37:12751.
Score: 0.006
-
Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
Score: 0.006
-
Incidence, Risk Score Performance, and In-Hospital Outcomes of Postoperative Atrial Fibrillation After Cardiac Surgery. Tex Heart Inst J. 2023 10 25; 50(5).
Score: 0.006
-
Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy. Tex Heart Inst J. 2023 08 22; 50(4).
Score: 0.006
-
COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. J Heart Lung Transplant. 2023 01; 42(1):33-39.
Score: 0.005
-
Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. 2023 Dec; 26(4):275-286.
Score: 0.005
-
Extracorporeal Membrane Oxygenation for COVID-19: Collaborative Experience From the Texas Medical Center in Houston With 2 Years Follow-Up. ASAIO J. 2022 12 01; 68(12):1443-1449.
Score: 0.005
-
Preoperative hyponatremia and survival after left ventricular assist device implantation. Artif Organs. 2022 Sep; 46(9):1923-1931.
Score: 0.005
-
Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022 Mar; 25(1):16-23.
Score: 0.005
-
Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs. 2021 Jun; 24(2):207-216.
Score: 0.005
-
Increasing Heart Transplant Volume by Expansion of Donor Heart Selection Criteria: A Single-Center Analysis. Transplant Proc. 2020 Apr; 52(3):949-953.
Score: 0.004
-
Left Ventricular Assist Device Outflow Graft Obstruction: A Complication Specific to Polytetrafluoroethylene Covering. A Word of Caution! ASAIO J. 2019 08; 65(6):e58-e62.
Score: 0.004
-
Outcomes of Lung Transplantation for Cystic Fibrosis in the Setting of Extensively Drug-Resistant Organisms. Prog Transplant. 2019 09; 29(3):220-224.
Score: 0.004
-
Early signatures of bleeding and mortality in patients on left ventricular assist device support: novel methods for personalized risk-stratification. Biomarkers. 2019 Jul; 24(5):448-456.
Score: 0.004
-
Impact of donor lung pathogenic bacteria on patient outcomes in the immediate post-transplant period. Transpl Infect Dis. 2018 Dec; 20(6):e12986.
Score: 0.004
-
Increased blood transfusion and its impact in patients having tracheostomy while on extracorporeal membrane oxygenation. Perfusion. 2019 03; 34(2):143-146.
Score: 0.004
-
Expanding the donor pool: donation after cardiac death. Thorac Surg Clin. 2015; 25(1):35-46.
Score: 0.003
-
Clinical and morphologic features of acute, subacute and chronic cor pulmonale (pulmonary heart disease). Am J Cardiol. 2015 Mar 01; 115(5):697-703.
Score: 0.003
-
Spectroscopic limb monitoring in peripheral extracorporeal membrane oxygenation. Asian Cardiovasc Thorac Ann. 2015 Mar; 23(3):347-8.
Score: 0.003
-
Which is better: a miniaturized percutaneous ventricular assist device or extracorporeal membrane oxygenation for patients with cardiogenic shock? ASAIO J. 2013 Nov-Dec; 59(6):607-11.
Score: 0.003
-
Case series using the ROTAFLOW system as a temporary right ventricular assist device after HeartMate II implantation. ASAIO J. 2013 Jul-Aug; 59(4):456-60.
Score: 0.003
-
Pathologic correlates of heparin-free donation after cardiac death in lung transplantation. J Thorac Cardiovasc Surg. 2013 May; 145(5):e49-50.
Score: 0.003
-
Combined heart and liver transplantation: the Cleveland Clinic experience. Ann Thorac Surg. 2013 Jan; 95(1):179-82.
Score: 0.003
-
Outcomes of axillary artery side graft cannulation for extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2013 Apr; 145(4):1088-1092.
Score: 0.003
-
Donor lungs with pulmonary embolism evaluated with ex vivo lung perfusion. ASAIO J. 2012 Jul-Aug; 58(4):432-4.
Score: 0.003
-
Spontaneous coronary artery dissection in Ehlers-Danlos syndrome. Ann Thorac Surg. 2011 Nov; 92(5):1883-4.
Score: 0.002
-
Images in cardiology. Ventricular outflow tract papillary fibroelastoma presenting with non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2010 Jun 08; 55(23):2607.
Score: 0.002
-
TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo. Am J Surg. 2005 Jun; 189(6):675-9.
Score: 0.002
-
MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer. J Surg Res. 2002 Jan; 102(1):35-8.
Score: 0.001
-
TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. J Surg Res. 2002 Jan; 102(1):39-44.
Score: 0.001
-
Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer. J Gastrointest Surg. 2000 Nov-Dec; 4(6):614-9.
Score: 0.001
-
Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer. Cancer Res. 2000 Jun 15; 60(12):3207-11.
Score: 0.001
-
Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer. J Surg Res. 1999 Jan; 81(1):65-8.
Score: 0.001